Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Preclinical evaluation of novel GPR120 agonist for improved glucose control in obese mice

Sep. 1, 2014

University of Bath patents novel deuterated estradiol derivatives

Sep. 1, 2014

Dezima reports findings from phase IIb study of TA-8995 for dyslipidemia

Aug. 29, 2014

Amgen submits evolocumab BLA, reports Japanese phase III results

Aug. 29, 2014

Scientists in China disclose novel xanthine oxidase inhibitors

Aug. 29, 2014

Isis begins phase III study of ISIS-APOCIII Rx in familial chylomicronemia syndrome

Aug. 29, 2014

Repros Therapeutics' Androxal superior to AndroGel in pivotal phase III trial in hypogonadism

Aug. 28, 2014

Sientists at Cortendo patent new cytochrome P450 inhibitors

Aug. 28, 2014

Empagliflozin launched in the U.S. for type 2 diabetes

Aug. 27, 2014

Novel LXR agonists for the treatment of lipoprotein disorders

Aug. 27, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026